文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

住院神经康复中重度创伤性脑损伤患者诊断性睡眠研究的比较

Comparison of Diagnostic Sleep Studies in Hospitalized Neurorehabilitation Patients With Moderate to Severe Traumatic Brain Injury.
PubMed 文献 · Chest · 2020-05-06
一句话结论在TBI神经康复早期,3级便携睡眠监测与1级多导睡眠监测一致性较强,但非劣效性未成立,轻中度OSA存在低估风险。

该前瞻性临床 trial 在6个TBI模型系统研究点(2017年5月至2019年2月)纳入214例住院神经康复的中重度TBI患者(中位年龄42岁,急诊GCS 6分,至PSG时间52天),同步完成1级和3级睡眠监测。两种方法加权kappa=0.78(95%CI 0.72-0.83),一致性中至强,误分类主要发生在轻度睡眠呼吸暂停,因AHI被低估。中重度睡眠呼吸暂停患者多数(54/72)被正确分类。非劣效性未成立:所有AHI截断值的特异性下限(LCL范围0.807-0.943)达到最低可耐受特异性0.5,但敏感性下限(LCL范围0.665-0.764)未达到最低可耐受敏感性0.8。

要点

  • 在TBI神经康复早期患者中,3级便携睡眠监测与1级PSG的加权kappa=0.78(95%CI 0.72-0.83),一致性中至强。
  • 中重度睡眠呼吸暂停患者中54/72被3级睡眠监测正确分类,但轻症患者因AHI低估而误分类常见。
  • 非劣效性未成立:所有AHI截断值特异性下限0.807-0.943均达最低可耐受0.5,但敏感性下限0.665-0.764未达最低可耐受0.8。
  • 3级睡眠监测可能低估中重度AHI患者的疾病严重程度及轻度AHI患者的疾病存在,在TBI早期神经康复中需注意。

适用人群与场景

  • 住院神经康复的中重度创伤性脑损伤患者,中位年龄42岁,急诊GCS=6分,至多导睡眠监测时间52天。

研究设计与关键结果

  • 研究类型:前瞻性临床 trial,在6个TBI模型系统研究点开展,2017年5月至2019年2月。
  • 筛查与纳入:896例入院患者中449例筛查合格,345例同意,进一步筛查后263例合格并完成同步1级和3级睡眠监测,最终分析214例。
  • 主要一致性结果:加权kappa=0.78(95%CI 0.72-0.83),误分类主要发生于轻度睡眠呼吸暂停,因AHI低估。
  • 中重度睡眠呼吸暂停分类:54/72例被正确分类。
  • 非劣效性:未成立;所有AHI截断值的特异性下限0.807-0.943达到最低可耐受特异性0.5,但敏感性下限0.665-0.764未达到最低可耐受敏感性0.8。

证据类型、等级与局限

  • 证据类型:前瞻性临床 trial。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,尽管3级便携诊断测试相对于1级的非劣效性未成立,但睡眠呼吸暂停各指数一致性较强,中重度患者多数被正确识别;然而在TBI早期神经康复中,3级睡眠监测存在低估中重度AHI患者疾病严重程度及轻度AHI患者疾病存在的误分类风险。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: OSA is prevalent during a time of critical neural repair after traumatic brain injury (TBI). The diagnostic utility of existing sleep studies is needed to inform clinical management during acute recovery from TBI.

RESEARCH QUESTION: This study aimed to evaluate the non-inferiority and diagnostic accuracy of a portable level 3 sleep study relative to level 1 polysomnography in hospitalized neurorehabilitation patients with TBI.

STUDY DESIGN AND METHODS: This is a prospective clinical trial conducted at six TBI Model System study sites between May 2017 and February 2019. Of 896 admissions, 449 were screened and eligible for the trial, with 345 consented. Additional screening left 263 eligible for and completing simultaneous administration of both level 1 and level 3 sleep studies, with final analyses completed on 214 (median age = 42 years; ED Glasgow Coma Scale = 6; time to polysomnography [PSG] = 52 days).

RESULTS: Agreement was moderate to strong (weighted kappa = 0.78, 95% CI, 0.72-0.83) with the misclassification commonly occurring with mild sleep apnea due to underestimation of apnea hypopnea index (AHI). Most of those with moderate to severe sleep apnea were correctly classified (n = 54/72). Non-inferiority was not demonstrated: the minimum tolerable specificity of 0.5 was achieved across all AHI cutoff scores (lower confidence limits [LCL] range, 0.807-0.943), but the minimum tolerable sensitivity of 0.8 was not (LCL range, 0.665-0.764).

INTERPRETATION: Although the non-inferiority of level 3 portable diagnostic testing relative to level 1 was not established, strong agreement was seen across sleep apnea indexes. Most of those with moderate to severe sleep apnea were correctly identified; however, there was risk of misclassification with level 3 sleep studies underestimating disease severity for those with moderate to severe AHI and disease presence for those with mild AHI during early TBI neurorehabilitation.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Nakase-Richardson R, Schwartz DJ, Ketchum JM, et al. Comparison of Diagnostic Sleep Studies in Hospitalized Neurorehabilitation Patients With Moderate to Severe Traumatic Brain Injury. Chest. 2020. PMID: 32387522. doi:10.1016/j.chest.2020.03.083

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。